Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Augmedix (AUGX)
NASDAQ:AUGX
Holding AUGX?
Track your performance easily
AUGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.73 - $6.25
Previous Close$2.33
Volume36.50K
Average Volume (3M)859.47K
Market Cap
$115.17M
Enterprise Value$112.24M
Total Cash (Recent Filing)$28.20M
Total Debt (Recent Filing)$25.27M
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Nov 05, 2024EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding49,243,752
10 Day Avg. Volume57,404
30 Day Avg. Volume859,468
Standard Deviation0.34
R-Squared0.00075
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)11.10
Price to Sales (P/S)2.22
Price to Cash Flow (P/CF)-7.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit5.21
Enterprise Value/Ebitda-11.49
Forecast
1Y Price Target
$2.35Price Target Upside0.86% Upside
Rating ConsensusHold
Number of Analyst Covering4
Augmedix News
PremiumPress Releases
Augmedix to Join Forces with Commure
PremiumCompany Announcements
Augmedix Discusses AI Tool Success and Expansion PlansBulls Say, Bears Say
Bulls Say
AcquisitionAugmedix announced a definitive agreement to be acquired by healthcare technology company, Commure, Inc. in an all cash transaction for $139M in equity or $2.35 per share.
Product MarginsAugmedix's Go and Go Assist have lower price points, but higher margins than the company's existing Live and Notes products.
Revenue ProjectionsThe partnership with HCA Healthcare is a key driver behind revenue projections.
Bears Say
Competitive RisksA combination of more competition, slowing decision-making and existing customers shifting to Augmedix's lower cost offerings is behind the company lowering its 2024 revenue guidance.
Customer ShiftLive customers can give a 90-day notification to switch to the lower-cost Augmedix Go Assist, expecting a bigger drop in revenue in 2H24.
Revenue GuidanceManagement lowered 2024 revenue guidance to $52.0M-$55.0M, from $60.0M-$62.0M, up 19.3% at the midpoint.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AUGX FAQ
What was Augmedix’s price range in the past 12 months?
Augmedix lowest stock price was $0.73 and its highest was $6.25 in the past 12 months.
What is Augmedix’s market cap?
Currently, no data Available
When is Augmedix’s upcoming earnings report date?
Augmedix’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Augmedix’s earnings last quarter?
Augmedix released its earnings results on Aug 12, 2024. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.133 by -$0.027.
Is Augmedix overvalued?
According to Wall Street analysts Augmedix’s price is currently Undervalued.
Does Augmedix pay dividends?
Augmedix does not currently pay dividends.
What is Augmedix’s EPS estimate?
Augmedix’s EPS estimate is -$0.14.
How many shares outstanding does Augmedix have?
Augmedix has 49,428,062 shares outstanding.
What happened to Augmedix’s price movement after its last earnings report?
Augmedix reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.133. Following the earnings report the stock price went down -0.441%.
Which hedge fund is a major shareholder of Augmedix?
Among the largest hedge funds holding Augmedix’s share is Ardsley Advisory Partners. It holds Augmedix’s shares valued at N/A.
---
Augmedix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.35 (0.86% Upside)
$2.35 (0.86% Upside)
Blogger Sentiment
Bullish
AUGX Sentiment 83%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 525.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 3.7%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.31%
12-Months-Change
Fundamentals
Return on Equity
-329.77%
Trailing 12-Months
Asset Growth
22.40%
Trailing 12-Months
Company Description
Augmedix
Augmedix Inc humanizes the clinician-patient experience by enabling clinicians to focus on what matters most, delivering high-quality patient care. It converts natural clinician-patient conversation into medical documentation and provides real-time administrative support, including referrals, orders, and reminders. The service, which supports over 35 specialties, delivers timely, accurate and comprehensive medical documentation to several of the healthcare systems in the U.S. and to hundreds of independent clinicians nationwide. Augmedix focuses on saving clinicians 2-3 hours per day, improve clinician productivity by as much as 20%, and increase clinicians' satisfaction with work-life balance over 40%.
---
AUGX Earnings Call
Q1 2024
0:00 / 0:00
---
AUGX Stock 12 Month Forecast
Average Price Target
$2.35
▲(0.86% Upside)
Technical Analysis
Best Analysts Covering AUGX
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-29.24%
reiterated a buy rating 6 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -29.24% per trade.
---